Supriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. The company plans to achieve this goal by expanding its product basket with the addition of six to seven molecules, targeting areas such as anti-anxiety, anesthesia, and anti-diabetes.
Supriya Lifescience Ltd and Plasma Nutrition, Inc Announce Groundbreaking Collaboration in Protein Technology equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Following the announcement, shares of Supriya Lifescience surged by more than 7 per cent. At 3.45 PM, the shares were trading at Rs 278.00, up by 7.52 per cent.